Humankind Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Buy |
100,271
+4,892
| +5% | +$119K | 0.59% | 25 |
|
|
2025
Q1 | $2.42M | Sell |
95,379
-3,593
| -4% | -$91K | 0.63% | 24 |
|
|
2024
Q4 | $2.63M | Buy |
98,972
+15,319
| +18% | +$406K | 0.66% | 23 |
|
|
2024
Q3 | $2.42M | Buy |
83,653
+5,709
| +7% | +$165K | 0.87% | 19 |
|
|
2024
Q2 | $2.18M | Sell |
77,944
-22,153
| -22% | -$620K | 0.58% | 27 |
|
|
2024
Q1 | $2.78M | Buy |
100,097
+25,812
| +35% | +$716K | 0.73% | 23 |
|
|
2023
Q4 | $2.14M | Buy |
74,285
+13,406
| +22% | +$386K | 0.63% | 27 |
|
|
2023
Q3 | $2.02M | Sell |
60,879
-598
| -1% | -$19.8K | 0.84% | 20 |
|
|
2023
Q2 | $2.25M | Buy |
61,477
+2,279
| +4% | +$83.6K | 0.88% | 18 |
|
|
2023
Q1 | $2.42M | Buy |
59,198
+6,290
| +12% | +$257K | 1% | 14 |
|
|
2022
Q4 | $2.71M | Buy |
52,908
+2,009
| +4% | +$103K | 1.18% | 12 |
|
|
2022
Q3 | $2.23M | Buy |
50,899
+10,720
| +27% | +$469K | 1.07% | 15 |
|
|
2022
Q2 | $2.11M | Sell |
40,179
-1,680
| -4% | -$88.1K | 1.01% | 14 |
|
|
2022
Q1 | $2.17M | Buy |
41,859
+3,640
| +10% | +$188K | 0.89% | 16 |
|
|
2021
Q4 | $2.26M | Buy |
38,219
+2,216
| +6% | +$131K | 2.84% | 5 |
|
|
2021
Q3 | $1.55M | Sell |
36,003
-6,334
| -15% | -$272K | 2.36% | 9 |
|
|
2021
Q2 | $1.66M | Buy |
42,337
+15,300
| +57% | +$599K | 2.95% | 6 |
|
|
2021
Q1 | $980K | Buy |
+27,037
| New | +$980K | 3.01% | 7 |
|